06.24.24 Hovione, an integrated specialist contract development and manufacturing organization (CDMO) and provider of spray drying and particle engineering services, has opened a state-of-the-art continuous tableting (CT) line at its R&D center in Lisbon, Portugal.
Hovione launches new website for the Chinese Market
Diane Villax receives achievement award at Deloitt`s Investor Relations
Hovione again ranks among best employers in Portugal
Hovione and iBET announce creation of ViSync Technologies,innovative company
Hovione & GEA Strengthen Partnership to Advance Continuous Tableting Technology
LISBON, Portugal , Jan. 18, 2024 /PRNewswire/ -- Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, is delighted to announce that it has been recognized as a Top Employer in all four of its manufacturing sites. Hovione is the first ever company to be certified as a Top Employer in Macau.
Hovione acquires ExtremoChem and its portfolio of proprietary sugars
LISBON, Portugal, May 3, 2023 /PRNewswire/ -- Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, and H&T Presspart have entered in a strategic partnership to advance the development of Presspart's Sunriser© Capsule-based Dry Powder Inhaler platform. The demand for inhalable drugs that require higher drug loads and the delivery of cohesive materials has increased, making it necessary to develop more efficient solutions. To meet this demand, the two companies will work together to develop the Sunriser© Dry Powder Inhaler. This innovative and best-in-class capsule-based platform is flexible enough to address both the challenges of classic carrier-based and spray-dried engineered formulations.
LISBON, March 22, 2023 /PRNewswire/ -- Hovione and Laxxon Medical announced a strategic collaboration to advance the use of 3D screen printing technologies for the pharmaceutical industry. This partnership combines Laxxon´s expertise in 3D screen printing, based on their SPID®-Technology, with Hovione's product & process development, engineering and manufacturing expertise in pharmaceutical applications. Under the terms of the agreement, Hovione will establish the Laxxon Medical 3D screen printing technology at Hovione's cGMP production sites first in Portugal and later in the USA.